Literature DB >> 11794482

Diagnosis and differential diagnosis of acute transverse myelopathy. The role of neuroradiological investigations and review of the literature.

G Scotti1, S Gerevini.   

Abstract

Acute transverse myelopathy (ATM) is a clinical definition of an acute neurologic condition that reflects impairment of spinal cord function. The term "myelopathy" has a different meaning from "myelitis", even if the words are often confused. Both terms indicate spinal cord involvement by some pathological event; but while myelopathy does not imply any etiological factor, myelitis refers to inflammatory diseases of the spinal cord. Acute spinal pathology can be associated with intra-axial or extra-axial lesions; extra-axial spinal pathology, however, has more often a chronic and progressive presentation. In this paper, we discuss primarily intra-axial lesions with attention on the role of neuroradiological investigations in diagnosis and differential diagnosis. Magnetic resonance imaging is the modality of choice for diagnosis; it shows signal abnormalities, usually T2 hyperintensity, focal or extensive, gadolinium enhancement and sometimes cord swelling. Despite its high sensitivity, about 40% of acute transverse myelopathies remain undemonstrated. Concerning etiology (multiple sclerosis (MS), vasculitis, infection, autoimmune disorders) no clearly different and specific patterns have been found; however small multiple enhancing lesions are more suggestive of MS (or lupus) while extensive, multilevel abnormalities reflect vasculitis as in antiphospholipid antibody syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11794482     DOI: 10.1007/s100720100038

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  15 in total

1.  Parainfectious myelitis associated with parvovirus B19 infection.

Authors:  Franziska Scheibe; Jörg Hofmann; Klemens Ruprecht
Journal:  J Neurol       Date:  2010-03-26       Impact factor: 4.849

Review 2.  Cervical spondylotic myelopathy caused by violent motor tics in a child with Tourette syndrome.

Authors:  Da-Young Ko; Seung-Ki Kim; Jong-Hee Chae; Kyu-Chang Wang; Ji Hoon Phi
Journal:  Childs Nerv Syst       Date:  2012-10-07       Impact factor: 1.475

Review 3.  Infectious and inflammatory diseases of the central nervous system-the spectrum of imaging findings and differential diagnosis.

Authors:  Joseph M Rozell; Edward Mtui; Yu-Ning Pan; Shan Li
Journal:  Emerg Radiol       Date:  2017-08-22

4.  [Neurolisteriosis with acute myelitis].

Authors:  B K Nguyen-Huu; A Thümler; B Weisner; K Wernicke; W Müller-Forell; H Schmidt; K J Werhahn
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

5.  West Nile Virus: a case report with flaccid paralysis and cervical spinal cord: MR imaging findings.

Authors:  Greg Kraushaar; Rajesh Patel; Grant W Stoneham
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

6.  MR diffusion tensor imaging and fiber tracking in inflammatory diseases of the spinal cord.

Authors:  J Renoux; D Facon; P Fillard; I Huynh; P Lasjaunias; D Ducreux
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

7.  Acute myelopathy with normal imaging.

Authors:  Neil R Holland
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

8.  Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin.

Authors:  E Pavlou; A Gkampeta; K Kouskouras; A Evangeliou; F Athanasiadou-Piperopoulou
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

9.  MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?

Authors:  Rory M C Abrams; Farinaz Safavi; Stanley Tuhrim; Allison Navis; Jeremy Steinberger; Susan C Shin
Journal:  J Neurovirol       Date:  2021-06-08       Impact factor: 3.739

10.  A Rare Case of Spinal Cord Injury Following Thoracic Radiofrequency Ablation.

Authors:  Nicholas K Donohue; Christopher White
Journal:  Cureus       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.